FDA, CISA advise on genomic device software vulnerabilities

A software patch is available to prevent cybersecurity threats to patient care, genomic data and provider networks from software vulnerabilities in Illumina’s benchtop and production-scale genomic sequencing instruments.

Powered by WPeMatico